搜尋





搜尋





市場行情
/
股票
/
trvi
/

Trevi Therapeutics Inc

TRVI

添加自選

17.980USD

+0.445+2.54%

交易中（美東）報價延遲15分鐘

2.31B總市值

虧損本益比TTM

Trevi Therapeutics Inc

17.980

+0.445+2.54%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

TRVI 利潤表

您可以在這裡找到Trevi Therapeutics Inc的年度或季度收入報告，以深入了解Trevi Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

營業總收入

----

--0.00

----

--0.00

營業收入

----

--0.00

----

--0.00

營業費用

30.01%14.91M

-16.52%10.22M

-1.21%13.92M

3.26%13.72M

-3.66%11.47M

37.05%12.24M

55.74%14.09M

58.54%13.29M

57.42%11.91M

34.19%8.93M

7.61%9.04M

7.19%8.38M

7.66%7.56M

-19.53%6.66M

20.99%8.40M

-14.69%7.82M

-13.15%7.03M

-10.01%8.27M

-4.10%6.95M

23.66%9.17M

-6.37%8.09M

35.87%9.19M

-5.31%7.24M

-0.05%7.41M

79.53%8.64M

14.12%6.77M

54.33%7.65M

69.34%7.42M

53.15%4.81M

166.83%5.93M

--4.96M

--4.38M

--3.14M

--2.22M

研發費用

27.27%9.94M

-33.61%6.19M

-10.15%10.09M

-6.31%9.39M

-11.28%7.81M

43.11%9.33M

77.51%11.22M

71.53%10.02M

76.08%8.80M

50.98%6.52M

9.60%6.32M

14.48%5.84M

7.64%5.00M

-30.13%4.32M

22.28%5.77M

-21.47%5.10M

-16.89%4.64M

-5.81%6.18M

-2.28%4.72M

32.05%6.50M

-7.14%5.59M

36.01%6.56M

-14.55%4.83M

-10.98%4.92M

80.32%6.02M

6.63%4.82M

50.79%5.65M

60.74%5.53M

41.26%3.34M

183.04%4.52M

--3.75M

--3.44M

--2.36M

--1.60M

折舊攤銷及損耗

-8.11%34.00K

-18.42%31.00K

5.56%38.00K

0.00%38.00K

5.71%37.00K

8.57%38.00K

2.86%36.00K

11.76%38.00K

84.21%35.00K

133.33%35.00K

288.89%35.00K

325.00%34.00K

72.73%19.00K

25.00%15.00K

-30.77%9.00K

-33.33%8.00K

-15.38%11.00K

-7.69%12.00K

0.00%13.00K

9.09%12.00K

30.00%13.00K

44.44%13.00K

18.18%13.00K

10.00%11.00K

11.11%10.00K

-30.77%9.00K

--11.00K

150.00%10.00K

350.00%9.00K

1200.00%13.00K

----

--4.00K

--2.00K

--1.00K

營業利潤

-30.01%-14.91M

16.52%-10.22M

1.21%-13.92M

-3.26%-13.72M

3.66%-11.47M

-37.05%-12.24M

-55.74%-14.09M

-58.54%-13.29M

-57.42%-11.91M

-34.19%-8.93M

-7.61%-9.04M

-7.19%-8.38M

-7.66%-7.56M

19.53%-6.66M

-20.99%-8.40M

14.69%-7.82M

13.15%-7.03M

10.01%-8.27M

4.10%-6.95M

-23.66%-9.17M

6.37%-8.09M

-35.87%-9.19M

5.31%-7.24M

0.05%-7.41M

-79.53%-8.64M

-14.12%-6.77M

-54.33%-7.65M

-69.34%-7.42M

-53.15%-4.81M

-166.83%-5.93M

---4.96M

---4.38M

---3.14M

---2.22M

淨非營業利息收入（費用）

利息收入

----

122.83%1.90M

151.02%2.10M

48.73%1.41M

12.69%1.14M

-24.89%854.00K

-29.25%837.00K

-21.62%946.00K

-17.36%1.01M

1.79%1.14M

179.01%1.18M

518.97%1.21M

30425.00%1.22M

37133.33%1.12M

21100.00%424.00K

9650.00%195.00K

33.33%4.00K

-25.00%3.00K

-33.33%2.00K

--2.00K

--3.00K

-98.22%4.00K

-98.93%3.00K

----

389.13%225.00K

--280.00K

502.63%229.00K

28.89%58.00K

12.20%46.00K

----

--38.00K

--45.00K

--41.00K

利息費用

----

-100.00%0.00

0.00%12.00K

200.00%12.00K

300.00%12.00K

-92.16%12.00K

-94.81%12.00K

-98.54%4.00K

-98.97%3.00K

-48.14%153.00K

-23.51%231.00K

-11.33%274.00K

-3.63%292.00K

-0.34%295.00K

2.72%302.00K

0.32%309.00K

104.73%303.00K

--296.00K

--294.00K

--308.00K

--148.00K

----

--0.00

-100.00%0.00

----

--51.00K

--123.00K

--195.00K

特殊收入（費用）

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-440.00%-136.00K

-83.33%-11.00K

688.89%53.00K

---5.00K

--40.00K

---6.00K

---9.00K

----

100.00%0.00

66.73%-163.00K

93.93%-52.00K

-1380.00%-148.00K

---749.00K

---490.00K

---856.00K

---10.00K

其他非經營性收入（費用）

166.67%4.00K

-850.00%-15.00K

81.82%-2.00K

-40.00%-7.00K

-500.00%-6.00K

166.67%2.00K

-107.14%-11.00K

-103.27%-5.00K

-100.61%-1.00K

-101.04%-3.00K

--154.00K

--153.00K

--165.00K

--289.00K

--0.00

100.00%0.00

----

--0.00

---375.00K

----

稅前利潤

-27.64%-13.21M

26.91%-8.33M

10.97%-11.82M

0.31%-12.32M

5.12%-10.35M

-46.08%-11.40M

-72.13%-13.27M

-72.26%-12.36M

-70.26%-10.91M

-41.23%-7.80M

6.79%-7.71M

10.94%-7.17M

12.63%-6.41M

35.20%-5.53M

-14.06%-8.27M

17.76%-8.06M

12.54%-7.33M

10.31%-8.53M

1.84%-7.25M

-32.40%-9.80M

1.13%-8.39M

-45.33%-9.51M

-0.26%-7.39M

-0.65%-7.40M

-76.49%-8.48M

-8.46%-6.54M

-29.78%-7.37M

-50.54%-7.35M

-17.91%-4.81M

-152.77%-6.03M

---5.68M

---4.88M

---4.08M

---2.39M

所得稅

-81.82%-20.00K

-200.00%-16.00K

51.61%-15.00K

-162.50%-21.00K

-37.50%-11.00K

-11.11%16.00K

-138.46%-31.00K

73.33%-8.00K

-14.29%-8.00K

190.00%18.00K

-85.71%-13.00K

-650.00%-30.00K

-40.00%-7.00K

-233.33%-20.00K

-450.00%-7.00K

-100.00%-4.00K

66.67%-5.00K

-135.29%-6.00K

118.18%2.00K

86.67%-2.00K

-66.67%-15.00K

525.00%17.00K

-120.00%-11.00K

-200.00%-15.00K

-125.00%-9.00K

91.84%-4.00K

80.00%-5.00K

84.00%-4.00K

-512.50%-49.00K

---25.00K

---8.00K

除稅後利潤

-27.58%-13.19M

27.15%-8.32M

10.87%-11.80M

0.41%-12.30M

5.16%-10.34M

-45.95%-11.41M

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.90M

-42.07%-7.82M

6.87%-7.70M

11.26%-7.14M

12.66%-6.40M

35.39%-5.50M

-13.94%-8.27M

17.79%-8.05M

12.45%-7.33M

10.53%-8.52M

1.67%-7.25M

-32.64%-9.79M

1.20%-8.37M

-45.68%-9.52M

-0.18%-7.38M

-0.52%-7.38M

-76.45%-8.47M

-9.28%-6.54M

-30.26%-7.37M

-51.21%-7.35M

-18.54%-4.80M

-151.56%-5.98M

---5.65M

---4.86M

---4.05M

---2.38M

持續經營利潤

-27.58%-13.19M

27.15%-8.32M

10.87%-11.80M

0.41%-12.30M

5.16%-10.34M

-45.95%-11.41M

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.90M

-42.07%-7.82M

6.87%-7.70M

11.26%-7.14M

12.66%-6.40M

35.39%-5.50M

-13.94%-8.27M

17.79%-8.05M

12.45%-7.33M

10.53%-8.52M

1.67%-7.25M

-32.64%-9.79M

1.20%-8.37M

-45.68%-9.52M

-0.18%-7.38M

-0.52%-7.38M

-76.45%-8.47M

-9.28%-6.54M

-30.26%-7.37M

-51.21%-7.35M

-18.54%-4.80M

-151.56%-5.98M

---5.65M

---4.86M

---4.05M

---2.38M

反常淨利潤

----

--0.00

----

--0.00

歸属于母公司的淨利潤

-27.58%-13.19M

27.15%-8.32M

10.87%-11.80M

0.41%-12.30M

5.16%-10.34M

-45.95%-11.41M

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.90M

-42.07%-7.82M

6.87%-7.70M

11.26%-7.14M

12.66%-6.40M

35.39%-5.50M

-13.94%-8.27M

17.79%-8.05M

12.45%-7.33M

10.53%-8.52M

1.67%-7.25M

-32.64%-9.79M

1.20%-8.37M

-45.68%-9.52M

-0.18%-7.38M

-10.21%-7.38M

-37.73%-8.47M

11.10%-6.54M

-3.56%-7.37M

-12.12%-6.70M

-19.78%-6.15M

-110.99%-7.35M

---7.11M

---5.98M

---5.14M

---3.48M

優先股派息

----

--0.00

-100.00%0.00

-46.95%686.00K

21.33%1.55M

12.76%1.47M

--1.36M

--1.29M

--1.28M

--1.30M

歸屬普通股東的淨利潤

-27.58%-13.19M

27.15%-8.32M

10.87%-11.80M

0.41%-12.30M

5.16%-10.34M

-45.95%-11.41M

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.90M

-42.07%-7.82M

6.87%-7.70M

11.26%-7.14M

12.66%-6.40M

35.39%-5.50M

-13.94%-8.27M

17.79%-8.05M

12.45%-7.33M

10.53%-8.52M

1.67%-7.25M

-32.64%-9.79M

1.20%-8.37M

-45.68%-9.52M

-0.18%-7.38M

-10.21%-7.38M

-37.73%-8.47M

11.10%-6.54M

-3.56%-7.37M

-12.12%-6.70M

-19.78%-6.15M

-110.99%-7.35M

---7.11M

---5.98M

---5.14M

---3.48M

基本每股收益

-3.06%-0.09

46.95%-0.06

37.79%-0.08

22.81%-0.09

19.74%-0.09

-36.94%-0.11

-68.70%-0.13

-68.88%-0.12

-68.77%-0.11

7.83%-0.08

35.40%-0.08

64.29%-0.07

72.72%-0.06

69.77%-0.09

64.27%-0.12

58.35%-0.20

44.82%-0.24

45.39%-0.28

17.47%-0.34

-17.56%-0.49

9.26%-0.43

-41.52%-0.52

1.48%-0.41

-10.20%-0.41

-18.83%-0.48

23.33%-0.37

10.36%-0.41

3.27%-0.38

-19.78%-0.40

-110.99%-0.48

---0.46

---0.39

---0.33

---0.23

稀釋每股收益

-3.06%-0.09

46.95%-0.06

37.79%-0.08

22.81%-0.09

19.74%-0.09

-36.94%-0.11

-68.70%-0.13

-68.88%-0.12

-68.77%-0.11

7.83%-0.08

35.40%-0.08

64.29%-0.07

72.72%-0.06

69.77%-0.09

64.27%-0.12

58.35%-0.20

44.82%-0.24

45.39%-0.28

17.47%-0.34

-17.56%-0.49

9.26%-0.43

-41.52%-0.52

1.48%-0.41

-10.20%-0.41

-18.83%-0.48

23.33%-0.37

10.36%-0.41

3.27%-0.38

-19.78%-0.40

-110.99%-0.48

---0.46

---0.39

---0.33

---0.23

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Trevi Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 TRVI 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Trevi Therapeutics Inc 全年的淨利潤是多少？



Trevi Therapeutics Inc 2025 財年淨利潤為 -42.76M。

Trevi Therapeutics Inc 上一季度的淨利潤是多少？



Trevi Therapeutics Inc 最近一個季度的淨利潤為 -13.19M。

Trevi Therapeutics Inc 年度營業利潤是多少？



Trevi Therapeutics Inc 2025 財年的營業利潤為 -49.33M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。